Last checked at 20 Dec 2021 11:41
AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal
AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Immupharma Share News (IMM)
IMM Share
Price
IMM Share
News
IMM Share
Chat9
IMM Share
Trades24
IMM
Live RNS
IMM Share
Charts
IMM Level 2
Console
IMM Live
Share Price
IMM Broker
Ratings
IMM Directors
Deals
IMM Financial
Diary
IMM
Fundamentals
IMM Short
Positions
IMM
Media
Immupharma Information
Share Price Information for Immupharma (IMM)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
2.20
Bid:
2.10
Ask:
2.26
Change:
-0.205 (-8.60%)
Spread:
0.16 (7.619%)
Open:
2.21
High:
2.21
Low:
2.18
Prev. Close:
2.385
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.20 Dec 2021 11:22
ImmuPharma raises £3.55m to fund research pipeline
(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced subscriptions and a placing to raise £3.55m on Monday, to fund its research and development pipeline as well as general working capital.
Read more20 Dec 2021 10:15
ImmuPharma surges after raise at "significant premium" to share price
ImmuPharma surges after raise at "significant premium" to share price
Read more29 Nov 2021 20:45
TRADING UPDATES: ImmuPharma teams with Imperial; Webis results delayed
TRADING UPDATES: ImmuPharma teams with Imperial; Webis results delayed
Read more29 Nov 2021 13:32
ImmuPharma signs two-year collaboration deal with Imperial College
(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced on Monday that it has signed a two-year collaboration agreement with Imperial College London.
Read more18 Nov 2021 20:53
TRADING UPDATES: Abingdon Health swings to loss; MetalNRG in dispute
TRADING UPDATES: Abingdon Health swings to loss; MetalNRG in dispute
Read more18 Nov 2021 15:16
ImmuPharma reports 'significant' progress since restructure
(Sharecast News) - Specialist drug discovery and development company ImmuPharma reported "significant" positive progress on Thursday, following major changes to its board and a restructuring of senior management in August.
Read more1 Oct 2021 11:47
IN BRIEF: Immupharma leaves Euronext Growth Brussels market
IN BRIEF: Immupharma leaves Euronext Growth Brussels market
Read more29 Sep 2021 20:31
IN BRIEF: ImmuPharma to make cost savings as it simplifies structure
IN BRIEF: ImmuPharma to make cost savings as it simplifies structure
Read more29 Sep 2021 13:22
EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens
EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens
Read more24 Aug 2021 15:08
DIRECTOR DEALINGS: Gamesys, Capital and ActiveOps execs sell shares
DIRECTOR DEALINGS: Gamesys, Capital and ActiveOps execs sell shares
Read more12 Aug 2021 14:17
IN BRIEF: Immupharma gets US FDA approval for Lupuzor pre-trial study
IN BRIEF: Immupharma gets US FDA approval for Lupuzor pre-trial study
Read more12 Aug 2021 13:02
FDA gives ImmuPharma go-ahead for pharmacokinetic study
(Sharecast News) - Specialist drug discovery and development company ImmuPharma said on Thursday that the United States Food and Drug Administration (FDA) has approved the start of the pharmacokinetic study as part of its new, "optimised" international phase 3 trial of 'Lupuzor'.
Read more30 Jul 2021 15:34
EXECUTIVE CHANGES: All change for ImmuPharma board as CEO departs
EXECUTIVE CHANGES: All change for ImmuPharma board as CEO departs
Read more16 Jul 2021 11:24
IN BRIEF: ImmuPharma appoints COO Tim Franklin to board of directors
IN BRIEF: ImmuPharma appoints COO Tim Franklin to board of directors
Read more